Amblyopia is defined as decrease of visual acuity in one eye when caused by abnormal binocular interaction or occurring in one or both eyes as a result of pattern vision deprivation during visual immaturity, for which no cause can be detected during the physical examination of the eye (s) and which in appropriate cases is reversible by therapeutic measures.\[[@ref1]\] With advent of optical coherence tomography (OCT), etiopathology of amblyopia is being better understood as it is one of the best tools to study the structural changes in retina.\[[@ref2]\] Occlusion therapy has long been the mainstay of amblyopia treatment.\[[@ref1]\] Various studies are available documenting changes in macular thickness (MT), foveal thickness (FT), and retinal nerve fibre layer thickness (RNFLT) in amblyopic eyes.\[[@ref3][@ref4][@ref5][@ref6][@ref7][@ref8]\] However, there are only few studies available on analysis of these parameters following occlusion therapy. Hence, the purpose of our study was not only to analyze the structural changes in retina (MT, FT, and RNFLT) in unilateral anisometropic amblyopic eyes and compare the same with the normal fellow eyes and normal eyes of normal children but also to understand the same following occlusion therapy.

Methods {#sec1-2}
=======

This prospective, interventional, comparative, longitudinal study was carried out at a tertiary care eye hospital in South India between October 2015 and June 2017. The study was approved by the institutional review board and adhered to all the principles mentioned in the Declaration of Helsinki 2000. Based on previous literature on outcome variable of visual acuity in LogMAR scale for 90% statistical power, 5% level of type 1 error, 10% type 2 error, and 95% confidence interval (CI) or at 5% level of significance, the estimated sample size was 60 children, 30 in each group. They were divided equally into two groups. Group 1 included children with unilateral anisometropic amblyopic eyes and normal fellow eyes (nonamblyopic eyes); group 2 included normal eyes of normal children. Inclusion Criteria: 1) Children of either sex aged between 5 and 18 years with unilateral anisometropic amblyopia (difference in best corrected visual acuity (BCVA) of ≥0.2 LogMAR between two eyes) were included in group 1. 2) Uncorrected visual acuity (UCVA) of LogMAR 0.00 in both eyes was included in group 2. 3) Children with normal neurological, ocular, and systemic examination. 4) Those willing for follow-up. Exclusion criteria: 1) Previous history of spectacle wear/occlusion therapy/ocular surgery. 2) Refractive error correction greater than 6 diopter spherical power and 3 diopter cylindrical power. 3) Presence of strabismus/nystagmus/hearing impairment/developmental delay. 4) Not compliant for spectacle wear and/or occlusion therapy. 5) Children who had poor fixation cooperation for SD OCT test, due to poor vision or lower age. 6) Children who have come for less than three follow-ups. After satisfying the inclusion and exclusion criteria, written informed consent from every child\'s parent or parents was taken after counseling them regarding the nature of the study. In group 2, first two normal children attending the outpatient department every day were recruited in the study. Detailed history regarding any ocular and systemic conditions was noted. UCVA and BCVA for distance using LogMAR three meter chart (English letters or symbols chart) and near vision using Snellen chart were recorded by a single person. All tests to rule out strabismus were done. Intraocular pressure was measured using noncontact tonometry wherever possible. Fundus examination was done using indirect ophthalmoscope and 20D condensing lens. Cycloplegic refraction using appropriate drug according to age was carried out in all children. Other visual function tests like color vision (Ishihara pseudo isochromatic plates), contrast sensitivity (Pelli--Robson contrast sensitivity chart), visual fields (Humphrey\'s field analysis/confrontation test/Amsler\'s chart), and electrophysiology tests were recorded wherever it was required and possible. Detailed ophthalmological examination both anterior and posterior segment was carried out in all children. OCT examinations were performed using a spectral domain optical coherence tomography (SD OCT) device (Topcon 3D Maestro 2000 series, Tokyo, Japan) by the same operator through dilated pupils of at least 5 mm in diameter. "Fast RNFL map protocol" consisting of three circular scans with diameters of 3.4 mm centered on the optic disc was performed along with the "Macular Thickness Map" protocol consisting of six radial scan lines centered on the fovea, each having a 6 mm transverse length. In order to obtain the best image quality, focusing and optimization settings were controlled and scans were accepted only if the signal strength (SS) was \>6 (preferably 9--10). Scans with foveal decentration \[i.e. with center point thickness standard deviation (SD) \>10%\] were repeated. MT was measured using caliper tool 350 μm nasally from the fovea between internal limiting membrane and retinal pigment epithelium. FT was measured at the center of fovea using calliper tool between internal limiting membrane and retinal pigment epithelium. In RNFLT measurement, total RNFL thickness was taken in the study. All findings were recorded for both the groups. Average of right eye (RE) and left eye (LE) values were taken for all the parameters in group 2. One month after first visit (postspectacle wear), amblyopic children (group 1) were asked to patch the normal fellow eye for 4 hours per day and perform near activities such as reading, writing, drawing, mobile games, and computer work. Parents were insisted upon maintaining a diary regarding the same to check for compliance. Group 1 children were followed up with BCVA, MT, FT, and RNFLT at 3, 6, 9, and 12 months along with patch diary for children\'s compliance. Data were analyzed using SPSS software (Statistical Package for Social Science) and by using the paired Student 't' test.

Statistical methods: MT, FT, and RNFLT were considered as outcome variables. Amblyopia was considered as explanatory variable. Descriptive analysis was carried out by mean and standard deviation for quantitative variables, frequency, and proportion for categorical variables. Initially, the outcome parameters were compared between amblyopic and normal subjects by using independent sample *t*-test. The mean values of all the outcome variables within amblyopic subjects were compared between the amblyopic and nonamblyopic eye at each follow-up interval separately using paired *t*-test. The change in the outcome parameters over the follow-up period within the amblyopic eye was compared by one-way repeated measure analysis of variance (ANOVA). Software IBM SPSS Statistics for Windows, Version 22.0. (IBM Corp Armonk, NY; 2013) was used for statistical analysis.

Results {#sec1-3}
=======

A total of 60 children aged between 5 and 18 years were included in the analysis. Out of which 30 children had unilateral amblyopia (Group 1) and 30 children were normal (group 2). The mean age in group 1 and 2 were 9.77 ± 2.674 and 9.70 ± 2.20 years, respectively (*P* = 0.916). In group 1, 56.66% (17) and 43.33% (13) were male and female children, respectively. Likewise in group 2, 60% (18) and 40% (12) were male and female children, respectively. In group 1, 12 (40%) had right eye (RE) amblyopia and 18 (60%) had left eye (LE) amblyopia. In group 1, 7 (23.3%) children had myopia, 5 (16.7%) had hypermetropia and 18 (60%) had astigmatism. The baseline values of mean LogMAR BCVA, MT, FT, and RNFLT in group 1 amblyopic eyes were 0.63 ± 0.405, 286.9 ± 6.522 μm, 195.9 ± 8.462 μm, and 100.8 ± 6.240 μm and nonamblyopic eyes were 0.00 ± 0.00, 240 ± 10.447 μm, 159.27 ± 9.285 μm, and 98.63 ± 4.723 μm, respectively; in group 2 (average of RE and LE in normal patients), they were 0.00 ± 0.00, 239.8 ± 4.294 μm, 143.6 ± 4.610 μm, and 100.5 ± 2.895 μm, respectively.

At first visit, the difference in mean BCVA, MT, and FT between amblyopic eyes (0.63 ± 0.405, 286.9 ± 6.522 μm, and 195.90 ± 8.462 μm) and normal eyes of normal group (0.00 ± 0.00, 239.8 ± 4.294 μm, and 143.6 ± 4.610 μm) was statistically significant (*P* value \< 0.001). Similarly, the difference between amblyopic eyes and nonamblyopic eyes (0.00 ± 0.00, 240 ± 10.447 μm, and 159.27 ± 9.285μm) was statistically significant (*P* value \< 0.001). However, the difference in mean RNFLT between amblyopic eyes (100.87 ± 6.24μm) and normal eyes (100.5 ± 2.895 μm); and nonamblyopic eyes (98.63 ± 4.723 μm) was statistically not significant (*P* value: 0.802 and 0.131, respectively). The mean LogMAR BCVA in amblyopic eyes in visit 1 (baseline) and following occlusion therapy at 3, 6, 9, and 12 months were 0.63 ± 0.405, 0.56 ± 0.368, 0.51 ± 0.374, 0.46 ± 0.330, and 0.50 ± 0.318, respectively. An improvement in BCVA following occlusion therapy was seen in all patients. [Table 1](#T1){ref-type="table"} shows comparison of BCVA, MT, FT, and RNFLT between amblyopic eyes, nonamblyopic eyes, and normal eyes at various follow-ups. [Graph 1](#F1){ref-type="fig"} shows comparison of MT between amblyopic and nonamblyopic eyes at various follow-ups. [Graph 2](#F2){ref-type="fig"} shows comparison of FT between amblyopic and nonamblyopic eyes at various follow-ups. [Fig. 1](#F3){ref-type="fig"} shows OCT picture of macula of amblyopic eye at first visit and [Fig. 2](#F4){ref-type="fig"} shows OCT picture of macula of amblyopic eye at last visit following occlusion therapy.

###### 

Comparison of mean BCVA, MT, FT, and RNFLT between amblyopic eyes, nonamblyopic eyes, and normal eyes at various follow-ups

                       Group 1- Amblyopic eyes                                                                                  
  -------------------- ----------------------------------------------------------------------- --------------- ---------------- --------------
  1^st^ visit (0 M)    0.63±0.405                                                              286.9±6.022     195.90±8.462     100.87±6.241
  2^nd^ visit (3 M)    0.56±0.368                                                              280.77±7.677    188.800±8.903    99.30±4.843
  3^rd^ visit (6 M)    0.51±0.374                                                              272.83±9.476    182.633±7.924    99.03±5.555
  4^th^ visit (9 M)    0.46±0.330                                                              253.30±11.065   176.10±11.309    101.23±5.276
  5^th^ visit (12 M)   0.50±0.318                                                              248.90±11.681   169.467±10.941   99.43±5.722
                       Group 1-Normal fellow eyes                                                                               
  1^st^ visit (0 M)    0.00±0.00                                                               240±5.977       159.27±9.285     98.63±4.723
  *P*\<0.001           *P*\<0.001                                                              *P*\<0.001      *P* 0.131        
  2^nd^ visit (3 M)    0.00±0.00                                                               240.03±5.678    164.90±7.840     100.60±6.295
  *P*\<0.001           *P*\<0.001                                                              *P*\<0.001      *P* 0.368        
  3^rd^ visit (6 M)    0.00±0.00                                                               239.50±5.335    164.23±8.157     99.03±4.642
  *P*\<0.001           *P*\<0.001                                                              *P*\<0.001      *P* 1.000        
  4^th^ visit (9 M)    0.00±0.00                                                               240.83±5.977    164.63±7.981     99.03±5.314
  *P*\<0.001           *P*\<0.001                                                              *P*\<0.001      *P* 0.089        
  5^th^ visit (12 M)   0.00±0.00                                                               239.47±5.569    165.43±7.771     99.60±5.500
  *P*\<0.001           *P*\<0.001                                                              *P* 0.098       *P* 0.917        
                       Group 2- Normal eyes of normal children (average of RE and LE values)                                    
  1^st^ visit (0 M)    0.00±0.00                                                               239.8±4.294     143.6±4.610      100.5±2.895
  *P*\<0.001           *P*\<0.001                                                              *P*\<0.001      *P* -0.802       

BCVA: Best corrected visual acuity, MT: Macular thickness, FT: Foveal thickness, RNFLT: retinal nerve fiber thickness, M: month, RE: Right eye, LE: Left eye
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![OCT image of macular thickness of amblyopic eye: (a) at first visit- baseline, following occlusion therapy (b) at 6 months and (c) at 12 months](IJO-67-1016-g003){#F3}

![OCT picture of foveal thickness of amblyopic eye: (a) at first visit- baseline, following occlusion therapy (b) at 6 months and (c) at 12 months](IJO-67-1016-g004){#F4}

Correlation between improvement in BCVA and decrease in MT and FT: There is a weak negative correlation between change in MT amblyopic eye and change in BCVA amblyopic eye (*r* value: −0.026, *P* value: 0.891). There is also a weak negative correlation between change in FT amblyopic eye and change in BCVA amblyopic eye (*r* value: −0.020, *P* value: 0.917).

The subgroup analysis based on age group is represented with the mean differences, 95% CI and *P* values in [Table 2](#T2){ref-type="table"}. We have performed univariate and multivariate logistic regression analysis to identify factors independently associated with change in BCVA, change in FT and MT. We have considered age, gender, and baseline values of BCVA, MT, and FT as explanatory parameters. The findings are presented in [Table 3](#T3){ref-type="table"}. In the three groups of refractive error, myopia, hypermetropia, and astigmatism respectively, the mean change in BCVA was 0.24 ± 0.13, 0.36 ± 0.11, and 0.34 ± 0.22 (*P* value: 0.295); mean change in MT was 44.57 ± 9.5, 34.4 ± 6.5, and 36.5 ± 15.1 (*P* value: 0.194); mean change in FT was 25.86 ± 6.89, 28.6 ± 8.65, and 26.06 ± 9.19 (*P* value: 0.593); mean change in RNFLT was 3.57 ± 4.43, −0.6 ± 9.69, and 1.17 ± 7.3 (*P* value: 0.331).

###### 

Subage group comparison of mean of different parameters between first and fifth visit in group 1

  Time periods                                      Affected Eye Mean±SD   Mean difference   95% CI   *P*      
  ------------------------------------------------- ---------------------- ----------------- -------- -------- ---------
  Age group: 5-10 years (Amblyopic eyes, *n*=20)                                                               
  I. BCVA                                                                                                      
  1^st^ visit (Base line)                           0.70±0.46                                                  
  5^th^ visit                                       0.53±0.34              0.27              0.145    0.405    \<0.001
  II\. MT                                                                                                      
  1^st^ visit (Base line)                           288.20±6.62                                                
  5^th^ visit                                       251.40±12.51           36.800            30.099   43.501   \<0.001
  III.FT                                                                                                       
  1^st^ visit (Base line)                           197.55±7.66                                                
  5^th^ visit                                       169.75±11.80           27.800            23.662   31.938   0.004
  IV\. RNFLT                                                                                                   
  1^st^ visit (Base line)                           100.40±5.67                                                
  5^th^ visit                                       99.20±6.30             1.20              23.187   30.113   0.457
  Age group: 11-15 years (Amblyopic eyes, *n*=10)                                                              
  I. BCVA                                                                                                      
  1^st^ visit (Base line)                           0.51±0.25                                                  
  5^th^ visit                                       0.38±0.21              0.37              0.174    0.575    0.009
  II\. MT                                                                                                      
  1^st^ visit (Base line)                           284.40±5.82                                                
  5^th^ visit                                       243.90±8.23            40.50             32.935   48.065   \<0.001
  III.FT                                                                                                       
  1^st^ visit (Base line)                           192.60±9.42                                                
  5^th^ visit                                       99.90±4.61             1.900             -3.437   7.237    0.441
  IV\. RNFLT                                                                                                   
  1^st^ visit (Base line)                           101.80±7.50                                                
  5^th^ visit                                       99.90±4.61             1.900             -3.437   7.237    0.441

BCVA: Best corrected visual acuity, F: foveal thickness, MT: macular thickness, RNFLT: retinal nerve fiber thickness

###### 

Univariate and multivariate linear regression analysis

  Univariate linear regression analysis of factors influencing change in BCVA in the amblyopic eyes                                                         
  --------------------------------------------------------------------------------------------------- --------------------------------- --------- --------- ---------
  Age                                                                                                 -0.070                            -0.032    0.022     0.712
  Gender (Base line=female)                                                                           -0.200                            -0.214    0.66      0.066
  BCVA                                                                                                0.504                             0.078     0.385     0.004
  FT                                                                                                  0.161                             -0.005    0.012     0.395
  MT                                                                                                  0.216                             -0.005    0.017     0.252
  Univariate linear regression analysis of factors influencing change MT in the amblyopic eyes                                                              
  Age                                                                                                 0.262                             -0.549    44.037    0.009
  Gender (Base line=female)                                                                           -0.316                            -17.650   1.514     0.096
  BCVA                                                                                                -0.585                            -29.082   -8.785    0.001
  FT                                                                                                  0.044                             -0.532    0.668     0.670
  MT                                                                                                  0.457                             0.227     1.612     0.011
  Univariate linear regression analysis of factors influencing change FT in the amblyopic eyes                                                              
  Age                                                                                                 -357                              -2.260    0.013     0.053
  Gender (Base line=female)                                                                           -0.192                            -9.544    3.128     0.309
  BCVA                                                                                                0.004                             -7.943    8.097     0.985
  FT                                                                                                  0.159                             -0.222    0.537     0.402
  MT                                                                                                  -0.034                            -0.542    0.455     0.858
  Multivariate linear regression analysis of factors influencing change MT in the amblyopic eyes                                                            
                                                                                                      Adjusted Regression coefficient                       
  BCVA                                                                                                -0.676                            -29.460   -14.244   \<0.001
  MT                                                                                                  4.930                             0.664     1.610     \<0.001

BCVA: Best corrected visual acuity, FT: foveal thickness, MT: macular thickness

Discussion {#sec1-4}
==========

Amblyopia had been thought to be a disease associated with an abnormality of the retina.\[[@ref9]\] However, amblyopia-induced cerebral changes were later shown to mainly occur in the visual cortex and the lateral geniculate body. In an experimental study, Von Noorden *et al*. have suggested that the mechanism responsible for amblyopia may be inadequate visual stimulation of the fovea during early childhood, abnormal binocular interaction or incompatibility in the visual information received by the two eyes, or a mixture of these problems.\[[@ref10]\] Yen *et al*. hypothesized that the normal postnatal reduction (apoptosis) of retinal ganglion cells is arrested in amblyopia and predicted that this would cause increased RNFLT. If this does indeed occur, it is likely that the arrest of normal postnatal changes would result not only in increased RNFLT but also would affect the normal maturation of the macula, including movement of Henle\'s fibers away from the foveola and a decrease in foveal cone diameter. This would explain increased foveal thickness in cases of amblyopia. Furthermore, because of the reduced apoptosis of retinal ganglion cells, the thickness of the ganglion cell layer in the macula would also be increased.\[[@ref11]\] Absence of normal vision stimulation may also lead to less or no apoptosis of retinal ganglion cells in amblyopic eyes, eventually leading to thicker RNFL of the amblyopic eye than nonamblyopic eye.\[[@ref12][@ref13]\]

Few studies have suggested that there is no difference in macular or RNFL thicknesses in children with unilateral amblyopia.\[[@ref14][@ref15][@ref16][@ref17]\] On the contrary, few studies, however, have shown that thickening of the RNFL occurs in anisometropic and strabismic amblyopia.\[[@ref11][@ref12]\] Huynh *et al*. and Pang *et al*. showed a thicker fovea in unilateral amblyopia,\[[@ref18][@ref19]\] while Al-Haddad *et al*. found a thicker macula in anisometropic amblyopia.\[[@ref6]\] Other studies, however, have shown thickening of RNFL, macula, and fovea in children with amblyopia.\[[@ref3][@ref5][@ref6][@ref11][@ref18]\] The results of various studies is shown in [Table 4](#T4){ref-type="table"}. OCT is a rapid, noninvasive, office-based imaging technique allowing objective quantification of retinal structures with high resolution, including determination of peripapillary RNFL thickness and macular thickness.

###### 

MT, FT, and RNFLT in amblyopic eyes among various studies

  Studies (author, year)                 Study size (*n*)   Age (years)   Type of amblyopia   OCT type     RNFLT           MT                   FT
  -------------------------------------- ------------------ ------------- ------------------- ------------ --------------- -------------------- -------------------------------------------
  Yen *et al*.\[[@ref11]\] (2004)        38                 26.4±18.3     M                   TDOCT (2)    increased       not studied          
                                         18                 25.4±18.6     A                                increased       not studied          
                                         20                 27.4±18.6     S                                no difference   not studied          
  Yoonet al.\[[@ref5]\]                  31                 7.7 (5-12)    HA                  TD-OCT (3)   increased       not studied          
  Kee *et al*.\[[@ref15]\] (2006)        26                 8 (4-12)      M                   TD-OCT (3)   no difference   no difference        
                                         6                  4 to 12       S                                no difference   no difference        no difference
  Hunyh *et al*.\[[@ref18]\] (2009)      48                 6 and 12      M                   TD-OCT (3)   no difference   increase FMT         
  Pang *et al*.\[[@ref3]\] (2011)        31                 9.6 (5-18)    M                   TD-OCT (3)   not studied     no difference        
  AL-Haddad *et al*.\[[@ref6]\] (2011)   45                 20±12         M                   SD-OCT       no difference   no difference        
  Alotaibi *et al*.\[[@ref7]\] (2011)    93                 8.7 (5-12)    M                   OCT          increased       no difference        
                                         36                               S                                increased       no difference        
                                         33                               A                                increased       increase MT and FV   
                                         24                               AS                               increased       no difference        
  Rajvi Z\[[@ref17]\] (2014)             93                 7±2           A                   SD-OCT       not studied     no difference        increased in moderate to severe amblyopia
  Atakan *et al*.\[[@ref8]\] (2015)      30                 6 to 25       S                   SD-OCT       no difference   no difference        no difference
                                         31                 7 to 15       A                                no difference   no difference        no difference
  Yoon and Chun\[[@ref20]\] (2017)       22                 3 to 9        A                   OCT          not studied     no difference        no difference
  Kasem and Badawi\[[@ref23]\] (2017)    64                 7 to 32       A                   OCT          increased       increased            

MT: macular thickness, FT: foveal thickness, FV: foveal volume, RNFLT: retinal nerve fibre layer thickness, M: Mixed amblyopia, A: anisometropic amblyopia, HA: Hyperopic amblyopia S: strabismic amblyopia, SD-OCT: spectral domain OCT, TD-OCT: time domain OCT

In our study, of 60 children with anisometropic amblyopia, the MT was more in amblyopic eyes (286.9 ± 6.52 μm) compared to nonamblyopic fellow eyes (240 ± 10.45 μm) and normal eyes of normal children (239.8 ± 4.294 μm). This difference which was statistically significant and was similar to other studies.\[[@ref4][@ref11][@ref13][@ref17]\] In our study, FT was significantly more (*P* \< 0.001) in amblyopic eyes (195.9 ± 8.462 μm) compared to normal fellow eyes (159.27 ± 9.285 μm) and normal eyes of normal children (143.6 ± 4.610 μm). This difference was statistically significant. Similar results were found in other studies.\[[@ref6][@ref13][@ref20]\] With respect to RNFLT, we found no statistically significant difference in amblyopic eyes compared to normal fellow eyes and normal eyes of normal children. This was consistent with other studies.\[[@ref14][@ref15][@ref16][@ref17]\] [Table 2](#T2){ref-type="table"} shows the MT, FT, and RNFLT among various studies. Furthermore, on analyzing the effectiveness of occlusion therapy on BCVA, MT, FT, and RNFLT at 3, 6, 9, and 12 months, we found an improvement in BCVA in all patients following occlusion therapy at the end of 1 year, minimum improvement being two letters seen in two children and maximum being five lines seen in five children. We found statistically significant reduction in MT and FT on each visit compared to baseline \[visit 1\], but there was no statistically significant difference in RNFLT, post occlusion therapy in amblyopic eyes. Tugcu *et al*. studied macular thickness in the persistent amblyopic and resolved amblyopic eyes and did not find significant difference between the two groups.\[[@ref21]\] Chen *et al*. compared the macular thickness of the amblyopic eyes with those of fully corrected previous amblyopic eyes and nonamblyopic controls and found there was no significant difference among the three groups.\[[@ref22]\] In contrast, Pang *et al*. reported that the central macular thickness in myopic anisometropic amblyopia significantly reduced after amblyopia treatment.\[[@ref19]\] However, the measurements in their study were not adjusted for axial length and refractive error. Analysis on correlation between BCVA and MT and FT showed a weak negative correlation which implies that with improvement of BCVA in amblyopic eyes following occlusion therapy there was normalization (or reduction) of MT and FT as revealed in OCT.

In group 1, on subage group analysis and comparison between 5 and 10 years (20 children) and 11--15 years (10 children), we observed a definite change (difference between first and last visit) in BCVA (0.17/0.13), MT (36.80/40.60), and FT (27.80/23.80) following occlusion therapy but there was no much change in RNFLT in both the groups (1.20/1.10). The change was greater in BCVA improvement and reduction of FT in 5--10 years age group, whereas the change was greater in reduction of MT in 11--15 years. The difference in RNFLT between the two groups was minimal. However, differences between both the subage groups are not statistically significant. There is no specific reason that we could attribute to this difference and trend in findings among the two age groups. However, larger and equal sample size is required to understand.

Following occlusion therapy, the mean BCVA change was greatest in the hypermetropic group (five children) which is revealed by the maximum change in FT, although least change was seen on MT. However with least change in BCVA in the myopic group (seven children), maximum change was noted on MT. This observation made may not be significant because the number of children in each subage group and each refractive error group is not the same, our criteria were only to include children with unilateral anisometropic amblyopia. To analyze in detail, we need larger and same numbers in each subgroup (based on both age wise and type of refractive error) and with longer follow-up period.

On univariate and multivariate linear regression analysis, none of the baseline parameters had shown any statistically significant association with change in BCVA and FT in the affected eye; however, univariate linear regression analysis showed baseline BCVA and baseline MT values to have statistically significant association with change in MT. Multivariate linear regression analysis showed base line BCVA to be negatively associated with change in MT (*P* value \< 0.001) and baseline MT to be positively associated with change in MT (*P* value \< 0.001).

Limitations: It is difficult to establish the independent association between various factors like age, gender, and type of refractive error and severity of refractive error. Subgroup analysis may not give any meaningful conclusions due to small sample size. Hence, we consider this as limitation of the study. Bilateral refractive, strabismic, and visual deprivation amblyopia were not included in the study. Choroidal thickness and different layers of retina were not analyzed. Sustainability of the improved BCVA and changes in anatomical layers of retina following discontinuation of occlusion therapy could not be assessed.

Conclusion {#sec1-5}
==========

MT and FT which were more in amblyopic eyes as compared to normal fellow eyes and normal eyes of normal children, decreased with improvement in BCVA after occlusion therapy. However, there was no difference in RNFLT between amblyopic eyes and normal fellow eyes and normal eyes of normal children before and after occlusion therapy. Therefore, we can hypothesize that occlusion therapy can help in restoring the process of postnatal reduction of ganglion cells as evidenced by reduction in MT and FT on OCT. We suggest that further larger studies addressing the limitations of the current study are needed to validate the results of the current study.
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